Avenu Medical Overview
- Founded
-
2010

- Status
-
Acquired/Merged
- Employees
-
40

- Latest Deal Type
-
M&A
Avenu Medical General Information
Description
Developer of a vascular therapeutic device created to pursue unmet clinical needs in the vascular access markets. The company's device is an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous fistula for hemodialysis access, thereby enabling hospitals to treat patients with chronic kidney diseases.
Contact Information
Website
www.avenumedical.com
Formerly Known As
Caymus Medical
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- 27123 Calle Arroyo
- Suite 2101
- San Juan Capistrano, CA 92675
- United States
+1 (949) 000-0000
Avenu Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 000.00 | Completed | Generating Revenue | |||
6. Debt - PPP | 03-May-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC | 31-Oct-2018 | 0000 | 000.00 | Completed | Generating Revenue | |
4. Later Stage VC (Series C) | 15-Feb-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC (Series B) | 15-Dec-2015 | 00.00 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series A) | 03-May-2011 | $1.44M | $2.44M | 00.000 | Completed | Startup |
1. Seed Round | 28-Sep-2010 | $1M | $1M | 000 | Completed | Startup |
Avenu Medical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.00 | |
Series B | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.00 | |
Series A | 5,500,000 | $0.001000 | $1 | $1 | 1x | $1 | 25.85% | |
Series S | 2,500,000 | $0.001000 | $0.4 | $0.4 | 1x | $0.4 | 11.75% |
Avenu Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a vascular therapeutic device created to pursue unmet clinical needs in the vascular access markets. The co
Therapeutic Devices
San Juan Capistrano, CA
40
As of 2020
000.00
0&0
000.00
Avenu Medical Competitors (18)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CardioFocus | Venture Capital-Backed | Marlborough, MA | 00 | 00000 | 00000000000 | 00000 |
00000000 0000000 0 | Venture Capital-Backed | Tel Aviv, Israel | 00 | 0000 | 00000000000 | 0000 |
00000000 | Formerly VC-backed | Mason, OH | 0000 | 0000 | 00000000 | 0000 |
0000000000000 | Corporation | New York, NY | 000 | 000.00 | 000000 - 000 | 000.00 |
00000 0000000 | Formerly VC-backed | Irvine, CA | 0000 | 00000 | 00000000 | 00000 |
Avenu Medical Patents
Avenu Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210177508-A1 | Devices and methods for the creation of an inter-atrial shunt for the treatment of congestive heart failure | Pending | 12-Dec-2019 | 0000000000 | |
EP-3829457-A4 | Fixation of vessels for percutaneous fistula creation | Pending | 03-Aug-2018 | 00000000000 | 0 |
EP-3829457-A1 | Fixation of vessels for percutaneous fistula creation | Pending | 03-Aug-2018 | 00000000000 | |
US-20200038026-A1 | Fixation of vessels for percutaneous fistula creation | Active | 03-Aug-2018 | 000000000 | |
US-11083460-B2 | Fixation of vessels for percutaneous fistula creation | Active | 03-Aug-2018 | A61B17/1227 |
Avenu Medical Executive Team (7)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mark Ritchart | Co-Founder, Chief Executive Officer & President | ||
Jeffrey Hull | Co-Founder | ||
David Campbell | Vice President, Quality Assurance and Regulatory Affairs |
Avenu Medical Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Mark Ritchart | Avenu Medical | Co-Founder, Chief Executive Officer & President | 000 0000 |
Avenu Medical Signals
Avenu Medical Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Pond Capital | Venture Capital | Minority | 000 0000 | 000000 0 |